APPLICATION
ANDA214650
TYPE
ANDA
ORIGINAL APPROVAL
2021-03-17
LATEST ACTION
2024-10-23
ROUTE
ORAL
DOSAGE FORM
GRANULE
MARKETING STATUS
Prescription
Products
DEFERASIROXPrescription
DEFERASIROX 360MG · GRANULE · ORAL
DEFERASIROXPrescription
DEFERASIROX 90MG · GRANULE · ORAL
DEFERASIROXPrescription
DEFERASIROX 180MG · GRANULE · ORAL
Approval history
2024-10-23Labeling · Supplement 3 · standardAP
2021-03-17UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.